单次肌松药全身麻醉下进行神经外科手术的可行性(3)
 |
| 第1页 |
参见附件(3141KB，3页)。
[6] Avidan MS，Zhang L，Burnside BA，et al. Anesthesia awareness and the bispectral index [J]. N Engl J Med，2008，358(11)：1097-1108.
[7] Maurtua MA，Deogaonkar A，Bakri MH，et al. Dosing of remifentanil to prevent movement during craniotomy in the absence of neuromuscular blockade [J]. J Neurosurg Anesthesiol，2008，20(4)：221-225.
[8] Murphy GS，Szokol JW，Marymont JH，et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit [J]. Anesth Analg，2008，107(1)：130-137.
[9] Sandin RH，Enlund G，Samuelsson P，et al. Awareness during anaesthesia：a prospective case study [J]. Lancet，2000，355(9205)：707-711.
[10] Yip PC，Hannam JA，Cameron AJ，et al. Incidence of residual neuromuscular blockade in a post-anaesthetic care unit [J]. Anaesth Intensive Care，2010，38(1)：91-95.
[11] Murphy GS，Brull SJ. Residual neuromuscular block：lessons unlearned. Part I：definitions，incidence，and adverse physiologic effects of residual neuromuscular block [J]. Anesth Analg，2010，111(1)：120-128.
[12] Herbstreit F，Peters J，Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade：increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure [J]. Anesthesiology，2009，110(6)：1253-1260.
[13] Moerman AT，Herregods LL，De Vos MM，et al. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients [J]. Anesth Analg，2009，108(3)：828-834.
(收稿日期：2011-11-02 本文编辑：冯 婕)
您现在查看是摘要介绍页，详见PDF附件(3141KB，3页)。